Novomics
Yongdungpo
About Novomics
Novomics develops cancer treatment-linked diagnosis systems based on its expertise and knowledge in the field of molecular diagnosis. A significant strength of Novomics is its network of specialists and clinicians, as well as the knowledge gains made possible by technological advancements in the age of precision medicine. By embracing cutting-edge clinical, molecular biological, and academic achievements and forming close collaborative relationships with pharmaceutical companies and hospitals that are significant players in the medical industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.3M
- Funding stage: IPO
- Last round: Series C (Jan 2017)
- Ticker: krx:283100
- Website: novomics.com
Industries & Categories
Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/novomics-202946 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.